4//SEC Filing
Janda Kim 4
Accession 0001209191-21-071311
CIK 0000850261other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 7:34 PM ET
Size
8.5 KB
Accession
0001209191-21-071311
Insider Transaction Report
Form 4
Janda Kim
Director
Transactions
- Sale
Common Stock
2021-12-27$5.88/sh−3,000$17,640→ 3,000 total - Exercise/Conversion
Non-qualified stock option
2021-12-27−3,000→ 0 totalExercise: $4.00From: 2013-01-01Exp: 2022-02-06→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2021-12-27$4.00/sh+3,000$12,000→ 6,000 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001518466
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 7:34 PM ET
- Size
- 8.5 KB